These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 25066759)

  • 1. CpG-ODN class C-mediated immunostimulation and its potential against Trypanosoma evansi in equines.
    Manuja A; Kumar P; Kumar R; Kumar B; Singha H; Sharma RK; Yadav SC
    Int Immunopharmacol; 2014 Oct; 22(2):366-70. PubMed ID: 25066759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG-ODN Class C Mediated Immunostimulation in Rabbit Model of Trypanosoma evansi Infection.
    Kumar P; Kumar R; Manuja BK; Singha H; Sharma A; Virmani N; Yadav SC; Manuja A
    PLoS One; 2015; 10(6):e0127437. PubMed ID: 26039713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.
    Ren T; Wen ZK; Liu ZM; Qian C; Liang YJ; Jin ML; Cai YY; Xu L
    Cancer Invest; 2008 Jun; 26(5):448-55. PubMed ID: 18568766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immune responses induced by classes of CpG oligodeoxynucleotides in ovine lymph node and blood mononuclear cells.
    Booth JS; Nichani AK; Benjamin P; Dar A; Krieg AM; Babiuk LA; Mutwiri GK
    Vet Immunol Immunopathol; 2007 Jan; 115(1-2):24-34. PubMed ID: 17067685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of interleukin-6 and interleukin-12 in bovine B lymphocytes, monocytes, and macrophages by a CpG oligodeoxynucleotide (ODN 2059) containing the GTCGTT motif.
    Zhang Y; Shoda LK; Brayton KA; Estes DM; Palmer GH; Brown WC
    J Interferon Cytokine Res; 2001 Oct; 21(10):871-81. PubMed ID: 11711000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunostimulatory effect of CpG oligodeoxynucleotides on peripheral blood mononuclear cells of healthy dogs and dogs with atopic dermatitis.
    Jassies-van der Lee A; Rutten V; Spiering R; van Kooten P; Willemse T; Broere F
    Vet J; 2014 Apr; 200(1):103-8. PubMed ID: 24461202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxycytidyl-deoxyguanosine oligonucleotide classes A, B, and C induce distinct cytokine gene expression patterns in rhesus monkey peripheral blood mononuclear cells and distinct alpha interferon responses in TLR9-expressing rhesus monkey plasmacytoid dendritic cells.
    Abel K; Wang Y; Fritts L; Sanchez E; Chung E; Fitzgerald-Bocarsly P; Krieg AM; Miller CJ
    Clin Diagn Lab Immunol; 2005 May; 12(5):606-21. PubMed ID: 15879022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation.
    Datta N; Mukherjee S; Das L; Das PK
    Eur J Immunol; 2003 Jun; 33(6):1508-18. PubMed ID: 12778468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine production and proliferation upon in vitro oligodeoxyribonucleotide stimulation of equine peripheral blood mononuclear cells.
    Wattrang E; Palm AK; Wagner B
    Vet Immunol Immunopathol; 2012 Apr; 146(2):113-24. PubMed ID: 22397968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunostimulatory DNA activates production of type I interferons and interleukin-6 in equine peripheral blood mononuclear cells in vitro.
    Wattrang E; Berg M; Magnusson M
    Vet Immunol Immunopathol; 2005 Sep; 107(3-4):265-79. PubMed ID: 15955566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity.
    Whitmore MM; DeVeer MJ; Edling A; Oates RK; Simons B; Lindner D; Williams BR
    Cancer Res; 2004 Aug; 64(16):5850-60. PubMed ID: 15313929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
    Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
    Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of oligodeoxyribonucleotides that induce interferon (IFN)-alpha in the pig and the phenotype of the IFN-alpha producing cells.
    Domeika K; Magnusson M; Eloranta ML; Fuxler L; Alm GV; Fossum C
    Vet Immunol Immunopathol; 2004 Sep; 101(1-2):87-102. PubMed ID: 15261695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bovine and ovine blood mononuclear leukocytes differ markedly in innate immune responses induced by Class A and Class B CpG-oligodeoxynucleotide.
    Mena A; Nichani AK; Popowych Y; Ioannou XP; Godson DL; Mutwiri GK; Hecker R; Babiuk LA; Griebel P
    Oligonucleotides; 2003; 13(4):245-59. PubMed ID: 15000839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chloroquine protects mice from challenge with CpG ODN and LPS by decreasing proinflammatory cytokine release.
    Hong Z; Jiang Z; Liangxi W; Guofu D; Ping L; Yongling L; Wendong P; Minghai W
    Int Immunopharmacol; 2004 Feb; 4(2):223-34. PubMed ID: 14996414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Toll-like receptor 9 in cpG oligodeoxynucleotides-induced species-specific immune responses].
    Li N; Fan XG; Tang SE; Zhu C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):533-5. PubMed ID: 16320582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG oligodeoxynucleotide and double-stranded RNA synergize to enhance nitric oxide production and mRNA expression of inducible nitric oxide synthase, pro-inflammatory cytokines and chemokines in chicken monocytes.
    He H; MacKinnon KM; Genovese KJ; Kogut MH
    Innate Immun; 2011 Apr; 17(2):137-44. PubMed ID: 20083501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha 2-macroglobulin binds CpG oligodeoxynucleotides and enhances their immunostimulatory properties by a receptor-dependent mechanism.
    Anderson RB; Cianciolo GJ; Kennedy MN; Pizzo SV
    J Leukoc Biol; 2008 Feb; 83(2):381-92. PubMed ID: 17967834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.
    Gantner F; Hermann P; Nakashima K; Matsukawa S; Sakai K; Bacon KB
    Eur J Immunol; 2003 Jun; 33(6):1576-85. PubMed ID: 12778475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG-ODN inhibits airway inflammation at effector phase through down-regulation of antigen-specific Th2-cell migration into lung.
    Ashino S; Wakita D; Zhang Y; Chamoto K; Kitamura H; Nishimura T
    Int Immunol; 2008 Feb; 20(2):259-66. PubMed ID: 18156622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.